Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE)
The NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE) trial is registered for early breast cancer and aims to explore de-escalation of …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Time-Restricted Eating in Menopause and HOrmone-sensitive Breast Cancers (TREMHO) [NA]
A clinical trial registration for the TREMHO study evaluating time-restricted eating in menopausal individuals and in hormone-sensitive brea…
-
EMA approval · 2026-01-26EMA Authorised: Kisqali (ribociclib succinate) — Novartis Europharm Limited
The European Medicines Agency authorised Kisqali (ribociclib succinate) for breast cancer in the EU.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating HRS-8080 versus physician's choice in locally advanced and metastatic breast cancer; enrollment is current…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy [EARLY_Phase 1]
An early-phase clinical trial from the University of Oklahoma is investigating neuromodulation to reduce cardiovascular risks associated wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 )
A completed clinical trial comparing tumescent local anesthesia with general anesthesia for breast surgery, focusing on postoperative pain o…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Study on the Cosmetic Outcome and Safety Evaluation of 3D Printed Biodegradable Biological Mesh for One-Stage Breast Reconstruction After Radical Mastectomy [NA]
Clinical trial update on a study evaluating the cosmetic outcomes and safety of a 3D-printed biodegradable biological mesh for one-stage bre…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: DWIBS-MRI: An Adjunct to the Traditional Diagnostic Breast Imaging Evaluation
The document reports termination of a clinical trial evaluating DWIBS-MRI as an adjunct to traditional imaging for breast cancer diagnosis.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread [Phase 1]
This Phase 1 trial examines abemaciclib (LY2835219) in combination with other therapies for metastatic breast cancer; the study is active bu…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
The PROOFS-Registry study investigates premenopausal women with breast cancer who are optimally treated with ovarian function suppression an…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure [Phase 2, Phase 3]
A Phase 2/3 trial is planned to evaluate RC48 (disitamab vedotin) in combination with chemotherapy for HER2-positive advanced/metastatic bre…
-
CLINICAL_TRIALS other · 2026-01-26Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer [Phase 1]
Phase 1 clinical trial entry for abemaciclib (Verzenio) in non-small cell lung cancer and breast cancer. The study status is active but not …
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment [Phase 2]
A Phase 2 neoadjuvant trial is evaluating CDK4/6 inhibitors combined with endocrine therapy for hormone receptor-positive breast cancer; the…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: The Influence of Chemotherapy on Position Sense
A KU Leuven–sponsored clinical trial investigates how chemotherapy affects position sense in chemotherapy-induced peripheral neuropathy and …
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness [EARLY_Phase 1]
A Phase 1 clinical trial uses PET imaging with zirconium-89 labeled trastuzumab to predict response to HER2-targeted therapy in breast cance…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer [Phase 1]
Phase 1 study evaluating a personalized cancer vaccine immunotherapy in combination with a checkpoint inhibitor for triple-negative breast c…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts [NA]
A clinical trial is evaluating a novel fluorescent ductal needle to localize and sample micro-lesions in breast ducts, with recruitment ongo…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer [NA]
This is a clinical trial update for Project SOAR, focused on Black American women diagnosed with breast cancer. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer [Phase 4]
A Phase 4 clinical trial is evaluating whether the HSD3B1 (1245C) gene mutation affects treatment outcomes in Stage I–III breast cancer and …
-
EMA approval · 2026-01-23EMA Authorised: Ontruzant (trastuzumab) — Samsung Bioepis NL B.V.
EMA authorised Ontruzant (trastuzumab) from Samsung Bioepis NL B.V., a biosimilar to trastuzumab for breast and gastric cancers.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway [NA]
A completed trial evaluated the impact of an SMS reminder on attendance at scheduled breast cancer screening appointments in BreastScreen No…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study) [NA]
A clinical trial investigating the use of Indocyanine Green (ICG) fluorescence imaging to identify sentinel lymph nodes during mastectomy in…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Comparison of Efficacy of Regional Blocks in Breast Surgeries. [NA]
This completed clinical trial compared different regional anesthesia blocks for breast surgeries, examining pain scores and morphine consump…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of Niraparib in combination with Trastuzumab for metastatic HER2-positive breast cancer.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: CDK and Body Composition Study
A recruiting clinical trial evaluating the effects of CDK inhibitors on body composition in breast cancer patients.